Inhaled aerosols: emerging clinical methods
Inhaled aerosols: emerging clinical methods
The pattern of deposition of inhaled aerosols in the lungs of man in health and disease, in vivo, is reliant on multiple factors. The disease being targeted has a major influence on the eventual site of deposition. Obstructive lung disease alters the flow dynamics within the airways and restrictive lung diseases alters the ‘stiffness’ of the lungs and ability to inhale large volumes. There are multiple methods used to assess the fate of an inhaled aerosol within the lungs and the consequent clinical effect. Imaging allows visualization of inhaled aerosols via the use of labeling with radio-isotopes combined with imaging techniques such as planar scintigraphy, single photon emission computed tomography (SPECT) and positron emission tomography (PET). Computed tomography (CT), and magnetic resonance imaging (MRI) allow visualization of the structure of the lung and can also offer information of physiological dysfunction. Data from imaging can be related to physiological measurements of lung function and to clinical outcome. The combination of lung CT images with Computational Fluid and Particle Dynamics (CFPD) simulations has led to the development of personalized functional modeling of the airways to investigate disease in the small and large airways. All of these methods have advantages, disadvantages and limitations. None of these methods are able to directly visualize the small airways which is frequently the area of interest in lung disease. There are emerging methods of interest that may offer further data on the effects of inhaled therapeutic agents including novel MRI methods and use of micro-CT to investigate changes in small airway function. This chapter will summarize developments relating to inhaled aerosols and emerging clinical methods used to assess efficacy.
Aerosol deposition, Airway obstruction, CF, Clinical lung imaging, COPD, Lung function, Small airways disease
359-373
Conway, Joy
bbe9a2e4-fb85-4d4a-a38c-0c1832c32d06
Biddiscombe, Martyn
17fc5ca7-fd32-4696-8abd-7a29b1f7c2c1
Usmani, Omar
d82af618-00af-4424-94ba-694bce0d4855
5 February 2021
Conway, Joy
bbe9a2e4-fb85-4d4a-a38c-0c1832c32d06
Biddiscombe, Martyn
17fc5ca7-fd32-4696-8abd-7a29b1f7c2c1
Usmani, Omar
d82af618-00af-4424-94ba-694bce0d4855
Conway, Joy, Biddiscombe, Martyn and Usmani, Omar
(2021)
Inhaled aerosols: emerging clinical methods.
In,
Kassinos, Stavros, Bäckman, Per, Conway, Joy and Hickey, Anthony J.
(eds.)
Inhaled Medicines: Optimizing Development through Integration of In Silico, In Vitro and In Vivo Approaches.
Elsevier, .
(doi:10.1016/B978-0-12-814974-4.00014-6).
Record type:
Book Section
Abstract
The pattern of deposition of inhaled aerosols in the lungs of man in health and disease, in vivo, is reliant on multiple factors. The disease being targeted has a major influence on the eventual site of deposition. Obstructive lung disease alters the flow dynamics within the airways and restrictive lung diseases alters the ‘stiffness’ of the lungs and ability to inhale large volumes. There are multiple methods used to assess the fate of an inhaled aerosol within the lungs and the consequent clinical effect. Imaging allows visualization of inhaled aerosols via the use of labeling with radio-isotopes combined with imaging techniques such as planar scintigraphy, single photon emission computed tomography (SPECT) and positron emission tomography (PET). Computed tomography (CT), and magnetic resonance imaging (MRI) allow visualization of the structure of the lung and can also offer information of physiological dysfunction. Data from imaging can be related to physiological measurements of lung function and to clinical outcome. The combination of lung CT images with Computational Fluid and Particle Dynamics (CFPD) simulations has led to the development of personalized functional modeling of the airways to investigate disease in the small and large airways. All of these methods have advantages, disadvantages and limitations. None of these methods are able to directly visualize the small airways which is frequently the area of interest in lung disease. There are emerging methods of interest that may offer further data on the effects of inhaled therapeutic agents including novel MRI methods and use of micro-CT to investigate changes in small airway function. This chapter will summarize developments relating to inhaled aerosols and emerging clinical methods used to assess efficacy.
This record has no associated files available for download.
More information
Published date: 5 February 2021
Additional Information:
Publisher Copyright:
© 2021 Stavros Kassinos, Per Backman, Joy Conway and Anthony J. Hickey Published by Elsevier Inc. All rights reserved.
Copyright:
Copyright 2022 Elsevier B.V., All rights reserved.
Keywords:
Aerosol deposition, Airway obstruction, CF, Clinical lung imaging, COPD, Lung function, Small airways disease
Identifiers
Local EPrints ID: 456564
URI: http://eprints.soton.ac.uk/id/eprint/456564
PURE UUID: 870da5b9-9b2a-409f-8430-55425d8cb5f9
Catalogue record
Date deposited: 05 May 2022 16:34
Last modified: 05 Jun 2024 18:54
Export record
Altmetrics
Contributors
Author:
Joy Conway
Author:
Martyn Biddiscombe
Author:
Omar Usmani
Editor:
Stavros Kassinos
Editor:
Per Bäckman
Editor:
Joy Conway
Editor:
Anthony J. Hickey
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics